Skip to main content
OpenTrials

Clinical trial condition

Subcutaneous Emphysema

Explore clinical trials studying Subcutaneous Emphysema. Study availability and eligibility vary by location and protocol.

97 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Subcutaneous Emphysema trial results

Completed

Pharmacokinetic Study of ARALAST (Human Alpha1- PI)

NCT00242385

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Adelaide, South Australia, Australia
  • Woodville, South Australia, Australia
  • Fitzroy, Victoria, Australia
  • Nedlands, Western Australia, Australia
View Trial Details
Completed

Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)

NCT00396006

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Adelaide, South Australia, Australia
  • Melbourne, Victoria, Australia
  • Nedlands, Western Australia, Australia
  • Otahuhu, Auckland, New Zealand
View Trial Details
Completed

Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency

NCT00161707

Conditions
Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • Shands Hospital at the University of Florida Gainesville, Florida, United States
  • Cleveland Clinic Foundation, Department of Pulmonary and Critical Care Medicine Cleveland, Ohio, United States
  • The University of Texas Health Science Center at Tyler Tyler, Texas, United States
View Trial Details
Completed

Alpha-1 Foundation Research Registry

NCT00499941

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Medical University of South Carolina. Division of Pulmonary and Critical Care Medicine Charleston, South Carolina, United States
View Trial Details
Completed

Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency

NCT03114020

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • University of Miami Hospital Miami, Florida, United States
  • Pulmonary Health Physicians, PC Fayetteville, New York, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
  • University of Texas Health Science Center Tyler, Texas, United States
View Trial Details
Completed

Phase II, Safety and Efficacy Study of Kamada-alpha-1-antitrypsin (AAT) for Inhalation"

NCT02001688

Conditions
Alpha-1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • University of Florida, Pulmonary, Critical Care & Sleep Medicine Gainesville, Florida, United States
  • The University of Texas Health Science Center at Tyler Center for Clinical Research Tyler, Texas, United States
View Trial Details
Completed

International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With Emphysema

NCT01217671

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Emphysema, +8 more
Locations
  • Inspiration Research Limited Toronto, Canada
  • Seymour Health Centre Vancouver, Canada
  • Gentofte Hospital Hellerup, Denmark
  • Universitätsklinikum des Saarlandes Homburg/Saar, Germany
View Trial Details

Related conditions